Back to search

Japan· JP-1319739Q1134

ラタノプロスト

A latanoprost product containing ラタノプロスト, registered in Japan by 日本ケミファ, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

On Japan’s NHI price listATC S01EE01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedラタノプロストATCS01EE01REGISTER NO.JP-1319739Q1134PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Latanoprost is registered in 18 of 19 countries.

Countries holding a registration under ATC S01EE01 (latanoprost), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 10 of them publish a price we can compare per daily dose

Latanoprost · ATC S01EE01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ラタノプロスト
Manufacturer
日本ケミファ
Country
Japan (JP)
ATC code
S01EE01
ATC class
Latanoprost
Defined daily dose
0.1 ml, AT
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

173 interactions on record for latanoprost.

Graded by severity as the source publishes them — 173 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Latanoprost · interactions on record

173 records

Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee960c93-376a-4f1d-ac93-dcdb0ce06dde
GET /v1/drugs/ee960c93-376a-4f1d-ac93-dcdb0ce06dde?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.005%1mL",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1319739Q1134",
  "category": "外用薬",
  "price_yen": 232.1,
  "generic_name": "ラタノプロスト",
  "product_name_jp": null,
  "therapeutic_class": "1319",
  "transitional_expiry": null
}

See everything about latanoprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.